<DOC>
	<DOCNO>NCT02702986</DOCNO>
	<brief_summary>10 Patients Locally Advanced Pancreatic Cancer , responsive neoadjuvant treatment Stage-III disease submit imILT ( Immunostimulating Interstitial Laser Thermotherapy ) . Safety feasibility imILT LAPC evaluate primary objective . Secondary objective QoL imILT , study immune reaction imILT , oncological analysis patient suffer LAPC submit imILT .</brief_summary>
	<brief_title>Safety Feasibility imILT Locally Advanced Pancreatic Cancer ( LAPC )</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Diagnosis stage III locally advance pancreatic cancer No neoadjuvant treatment doable Eastern Cooperative Oncology Group performance status &lt; 1 No concomitant oncological treatment ( hormonal , immunotherapy , etc ) Suffering neoplasms Suffering HIV Suffering autoimmune disease Concomitant medication steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>